Ikarian Capital, LLC / SLNOEUR
Ikarian Capital, LLC’s Soleno Therapeutics Inc Position
Does Ikarian Capital, LLC own Soleno Therapeutics Inc (SLNOEUR)? Yes — 344.1K shares worth $12M (+0.94% of its 13F portfolio) as of Q1 2026, up from 68.8K shares the prior filed quarter.
Position Value
$12M
Q1 2026
Shares
344.1K
% of Portfolio
+0.94%
Quarters Held
15
currently held
Position History SLNOEUR
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q1 2026 | 344.1K | $12M | +0.94% |
| Q4 2025 | 68.8K | $3M | +0.25% |
| Q3 2025 | 55.9K | $4M | +0.38% |
| Q3 2024 | 221.4K | $11M | +1.56% |
| Q2 2024 | 445.5K | $18M | +3.17% |
| Q1 2024 | 565.4K | $24M | +2.65% |
| Q4 2023 | 590.2K | $24M | +2.22% |
| Q3 2023 | 536.7K | $16M | +1.91% |
| Q1 2022 | 128.5K | $29,000 | 0.00% |
| Q4 2021 | 121.7K | $50,000 | +0.01% |
| Q3 2021 | 121.7K | $112,000 | +0.01% |
| Q2 2021 | 122.5K | $140,000 | +0.01% |
| Q1 2021 | 122.5K | $155,000 | +0.01% |
| Q4 2020 | 122.5K | $236,000 | +0.01% |
| Q2 2020 | 336.8K | $748,000 | +0.06% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Ikarian Capital, LLC’s full portfolio or all institutional holders of SLNOEUR.